Since then, other GLP-1R agonists such as exenatide (Byetta ) and dulaglutide (Trulicity ) have been approve (Holman et al., 2017
A dosage of 0.75 mg of dulaglutide was highly effective in this clinical case
GLP1 GLP-1-1 GLP1GLP-12 GLP1 GLP-1 GLP-1 BMIkg (m) 2 25 GLP-1 GLP-1 GLP-1GLP-1 15 61012 12 120mL303mg1117mg 1,6501,100 QA 3mg7mg 3mg3mg47mg14mg 2 GLP-1 30 3030 2 GLP-1 2 GLP-1FDA28
Endocrinology (2013) 154:142433
Discontinuation studies for semaglutide and tirzepatide show 70-85% weight regain within 12-18 months after stopping treatment
By helping to reduce food intake and promote a feeling of fullness, Semaglutide supports weight management, which can be especially important for people with Type 2 diabetes, as excess weight often contributes to difficulties in managing blood sugar